Alzheimer's Disease. Specifically, It Will Term Paper

PAGES
4
WORDS
1397
Cite

Alzheimer's, on the other hand, directly affects brain cells, and if there is uncertainty, patients and their families should certainly ask for a second opinion. The population most likely to suffer from the disease is the elderly, but this is not always the case. Researchers note, "Alzheimer's disease is not part of the normal aging process, although it affects predominantly elderly people. Whereas only 10% of those 65 years of age and older are affected by this disease, the percentage may be as high as 48% in those 85 years of age and older" (Handy, Turnbull, Edwards, & Lancaster, 1998, p. 1-2). In addition, there are more rare forms that strike patients in middle age. These researchers write about, "a rare form of Alzheimer's that strikes in middle age and is passed down to 50%, on average, of offspring" (Tanzi & Parson, 2000, p. xiii). This form of the disease can spread among siblings, often attacking an entire family of brothers and sisters.

Currently, there is little in the way of prevention of this disease. Because a distinct cause is still unknown, an effective and lasting cure cannot be developed. Scientists understand that risk factors include advancing age, and a family history of the disease. Treatment is difficult, because there are so many differing forms of the disease, and scientists still do not know what causes it, or how it specifically affects the central nervous system. Some treatments include several different drug treatments with differing rates of success. Some of these drugs include: Hydergine, Tacrine, Donepezil, and many other drugs that affect specific portions of the brain. a-beta inhibitors have also been developed to deal with the disease, because of extensive research in this area. These researchers note, "As suddenly realized, the a-beta peptide wasn't just an abnormal brain byproduct derived from a cellular goof, but a molecule normally churned out by cells throughout the body. Only when it accumulated in the brain could it be considered a menace" (Tanzi & Parson, 2000, p. 212). All the major drug companies are working on different medications meant to treat Alzheimer's, because it is such a prevalent and devastating disease, and the elderly population is continually growing....

...

Some studies indicate that other healthy living factors, including "controlling blood pressure, weight and cholesterol levels; exercising both body and mind; and staying socially active" (Editors, 2004), may have a positive affect on controlling Alzheimer's, too.
Because of the natural progression of the disease, treatment is often continued at home, or in a nursing home, and it can be quite stressful on the caregivers. Dr. Edwards, an Alzheimer expert, continues, "Most often at the center is the person who becomes the primary caregiver - the spouse or a middle-aged child. Ultimately, the responsibility for the total care of the patient may fall on that individual. As dementia progresses, there will be increasing demands on the caregiver" (Edwards, 1994, p. 157). Caregiving can continue for years, and is often just as difficult for the caregiver as it is for the patient. Finding a cure or treatment for the disease will also help the millions of people involved in caring for Alzheimer's patients each year.

In conclusion, Alzheimer's is a deadly and costly disease. Studies show that even if the patient is healthy and free of other health problems, Alzheimer's will eventually cause death (Editors, 2004). It also costs Americans billions of dollars every year in health care, nursing facility, research, and home-care costs. Alzheimer's is a frightening disease with no known cure, and studies must continue to find the cause, and eventually find a cure for this devastating disease.

Sources Used in Documents:

References

Editors. (2004). About Alzheimer's. Retrieved from the Alzheimer's Association Web site: http://www.alz.org/AboutAD/WhatIsAD.asp12 Nov. 2004.

Edwards, a.J. (1994). When memory fails: Helping the Alzheimer's and dementia patient. New York: Plenum Press.

Handy, R.C., Turnbull, J.M., Edwards, J., & Lancaster, M.M. (Eds.). (1998). Alzheimer's disease: A handbook for caregivers. St. Louis, MO: Mosby.

Keltner, N.L., Zielinski, a.L., & Hardin, M.S. (2001). Drugs used for cognitive symptoms of Alzheimer's disease. Perspectives in psychiatric care, 37(1), 31.


Cite this Document:

"Alzheimer's Disease Specifically It Will" (2004, November 12) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/alzheimer-disease-specifically-it-will-59054

"Alzheimer's Disease Specifically It Will" 12 November 2004. Web.19 April. 2024. <
https://www.paperdue.com/essay/alzheimer-disease-specifically-it-will-59054>

"Alzheimer's Disease Specifically It Will", 12 November 2004, Accessed.19 April. 2024,
https://www.paperdue.com/essay/alzheimer-disease-specifically-it-will-59054

Related Documents

In light of the knowledge provided by these case studies, it is important to note certain flaws in the methodology of each cases study. The study in the case of midlife neuroticism, the researchers do not take into account pre- existing conditions such the brain structure and function associated with greater neuroticism. Failure to proper diagnosis might lead to early presentation of Alzheimer's disease in response to pathology. As for

2013: 1483). It notes that although genetic markers "are known for individuals of European ancestry, but whether the same or different variants account for the genetic risk of Alzheimer disease in African-American individuals" was unknown before the study (Reitz et al. 2013: 1483). In contrast, the Kolata piece seemed to suggest that the association was very much a 'known' quantity, even though it had not yet been directly proven.

Alzheimer's disease (AD) is one of the most researched ailments in the world of medicine. This discussion will explore the working hypothesis that caloric restriction may prevent Alzheimer's disease. In addition, the paper will explore the idea that individuals with the ApoE genotype and a higher intake of calories have a higher risk of AD than those who do not carry the apoE4 allele (diet-gene interaction). Let's begin the discussion

) Researcher believe that when Alzheimer's begins to attack, it hits the "factory" of cell groups that otherwise are functioning perfectly. There are breakdowns in the communications that the cell groups hitherto provided, and although scientists don't know precisely where the attack is first launched by Alzheimer's, but they do understand that "as the damage spreads, cells lose their ability to do their jobs and, eventually die, causing irreversible changes

After 13 months, the rats begin to show signs of dementia including reduced cognitive ability and memory impairment (McGill University, 2010). Amyloid B. immunotherapy Past research Past research on the effects of active or passive a? immunization on a? buildup and AD progression provided evidence that such immunization "protects against the progressive loss of synaptophysin in the hippocampal molecular layer and frontal neocortex of a transgenic mouse model of AD" (Buttini &

Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive